DK132075B - Analogifremgangsmåde til fremstilling af N-(4-aminophenyl)-N',N'-dimethylacetamidiner. - Google Patents

Analogifremgangsmåde til fremstilling af N-(4-aminophenyl)-N',N'-dimethylacetamidiner.

Info

Publication number
DK132075B
DK132075B DK286671AA DK286671A DK132075B DK 132075 B DK132075 B DK 132075B DK 286671A A DK286671A A DK 286671AA DK 286671 A DK286671 A DK 286671A DK 132075 B DK132075 B DK 132075B
Authority
DK
Denmark
Prior art keywords
dimethylacetamidines
aminophenyl
preparation
analogous process
analogous
Prior art date
Application number
DK286671AA
Other languages
English (en)
Other versions
DK132075C (da
Inventor
H Wollweber
W Flucke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK132075B publication Critical patent/DK132075B/da
Application granted granted Critical
Publication of DK132075C publication Critical patent/DK132075C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK286671A 1970-06-13 1971-06-11 Analogifremgangsmade til fremstilling af n-(4-aminophenyl)-n',n'-dimethylacetamidiner DK132075C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2029298A DE2029298C3 (de) 1970-06-13 1970-06-13 Aminophenylamidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
DK132075B true DK132075B (da) 1975-10-20
DK132075C DK132075C (da) 1976-03-15

Family

ID=5773920

Family Applications (1)

Application Number Title Priority Date Filing Date
DK286671A DK132075C (da) 1970-06-13 1971-06-11 Analogifremgangsmade til fremstilling af n-(4-aminophenyl)-n',n'-dimethylacetamidiner

Country Status (25)

Country Link
US (1) US3818070A (da)
JP (4) JPS563341B1 (da)
AR (1) AR205686A1 (da)
AT (3) AT311938B (da)
BE (1) BE768402A (da)
CA (1) CA1000713A (da)
CH (3) CH573902A5 (da)
CS (3) CS172348B2 (da)
DE (1) DE2029298C3 (da)
DK (1) DK132075C (da)
EG (1) EG10637A (da)
ES (3) ES392166A1 (da)
FR (1) FR2100756B1 (da)
GB (1) GB1325527A (da)
HK (1) HK29976A (da)
HU (1) HU162206B (da)
IE (1) IE35362B1 (da)
IL (1) IL37023A (da)
NL (1) NL7108066A (da)
PH (1) PH10292A (da)
PL (3) PL93694B1 (da)
RO (3) RO58997A (da)
SE (1) SE366028B (da)
SU (2) SU469244A3 (da)
ZA (1) ZA713766B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013676A (en) * 1970-06-13 1977-03-22 Bayer Aktiengesellschaft Aminophenylamidines, their production and their pharmaceutical use
DE2346939A1 (de) * 1973-09-18 1975-04-03 Bayer Ag Acylamino-phenyl-acetamidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4015012A (en) * 1973-09-18 1977-03-29 Bayer Aktiengesellschaft 4-Acylaminophenylacetamidines and a method for their preparation
US4140795A (en) * 1976-12-09 1979-02-20 Ciba-Geigy Corporation Pesticidal 1,3,5-triazapenta-1,4-dienes
DE2758005A1 (de) 1977-12-24 1979-06-28 Bayer Ag Phosphonylureidobenzol-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4525663A (en) * 1982-08-03 1985-06-25 Burr-Brown Corporation Precision band-gap voltage reference circuit
JPS6118603A (ja) * 1984-07-04 1986-01-27 極東開発工業株式会社 塵芥収集車における安全装置
JPS6230943U (da) * 1985-08-09 1987-02-24
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
AU8852901A (en) * 2000-09-07 2002-03-22 Bayer Corporation Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
UA78039C2 (en) * 2002-05-03 2007-02-15 Du Pont Amidinyl phenyl compounds, fungicide compositions and a method for controlling plants diseases
DE102007061262A1 (de) * 2007-12-19 2009-06-25 Bayer Animal Health Gmbh Neue Verwendung von Tribendimidin
DE102008030764A1 (de) * 2008-06-28 2009-12-31 Bayer Animal Health Gmbh Kombination von Amidin-Derivaten mit cyclischen Depsipeptiden
CN102344391B (zh) * 2011-07-28 2013-12-25 山东新华制药股份有限公司 N-(4-乙酰氨基苯基)-n′，n′-二甲基乙脒的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182053A (en) * 1961-11-20 1965-05-04 Hoffmann La Roche Pyridine formamidines of primary amines

Also Published As

Publication number Publication date
BE768402A (fr) 1971-12-13
RO58867A (da) 1976-05-15
SU450400A3 (ru) 1974-11-15
FR2100756A1 (da) 1972-03-24
RO62442A (fr) 1978-02-15
AT315820B (de) 1974-06-10
PL89670B1 (da) 1976-12-31
HU162206B (da) 1973-01-29
IE35362B1 (en) 1976-01-21
JPS55143953A (en) 1980-11-10
DK132075C (da) 1976-03-15
ES395640A1 (es) 1973-11-16
RO58997A (da) 1976-02-15
CH573900A5 (da) 1976-03-31
US3818070A (en) 1974-06-18
DE2029298A1 (de) 1971-12-23
ES392166A1 (es) 1974-02-01
FR2100756B1 (da) 1975-01-17
AR205686A1 (es) 1976-05-31
ES395639A1 (es) 1973-11-16
JPS563341B1 (da) 1981-01-24
JPS5634585B2 (da) 1981-08-11
AT313873B (de) 1974-03-11
PH10292A (en) 1976-11-08
GB1325527A (en) 1973-08-01
CS172348B2 (da) 1976-12-29
DE2029298C3 (de) 1980-04-17
EG10637A (en) 1976-04-30
JPS5634586B2 (da) 1981-08-11
AT311938B (de) 1973-12-10
IL37023A0 (en) 1971-08-25
SE366028B (da) 1974-04-08
ZA713766B (en) 1972-01-26
CS172349B2 (da) 1976-12-29
CS172350B2 (da) 1976-12-29
DE2029298B2 (de) 1979-08-02
IE35362L (en) 1971-12-13
PL93694B1 (da) 1977-06-30
IL37023A (en) 1975-08-31
PL93695B1 (da) 1977-06-30
CH573901A5 (da) 1976-03-31
JPS55143954A (en) 1980-11-10
CH573902A5 (da) 1976-03-31
SU469244A3 (ru) 1975-04-30
CA1000713A (en) 1976-11-30
JPS55143955A (en) 1980-11-10
JPS5748147B2 (da) 1982-10-14
NL7108066A (da) 1971-12-15
HK29976A (en) 1976-05-28

Similar Documents

Publication Publication Date Title
DK143799C (da) Fremgangsmaade til fremstilling af n-1,1,1-trisubstituerede methylazoler
DK140500B (da) Analogifremgangsmåde til fremstilling af N-(D-6-methyl-8-isoergolin-I-yl)-N',N'-diethylurinstof og salte heraf.
DK132174B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
DK132075B (da) Analogifremgangsmåde til fremstilling af N-(4-aminophenyl)-N',N'-dimethylacetamidiner.
DK123357B (da) Analogifremgangsmåde til fremstilling af N(6)-benzyl-adenosin-derivater.
DK140842B (da) Fremgangsmåde til fremstilling af 8,9-didebydro-10alfa-alkoxy-ergolener.
DK114058B (da) Fremgangsmåde til fremstilling af 2,4-disulfamyl-N-(3-hydroxy-2-propenyliden)-anilinderivater.
DK132795C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK127778B (da) Fremgangsmåde til fremstilling af 3',4'-dideoxy-kenamycin B.
DK127812B (da) Analogifremgangsmåde til fremstilling af 3,5-dibrom-zearalan.
AR194249A1 (es) Procedimiento para la preparacion de n-(2,4-dihalogen-s-triacin-6-il)ureas
DK132221B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
DK122129B (da) Analogifremgangsmåde til fremstilling af N,N'-dialkyl-4-phenylimidazolin-2-thioner.
SE396216B (sv) Forfarande for framstellning av n-(2-amino-3,5-dibrombensyl)-n-metylcyklohexylamin
DK130308B (da) Fremgangsmåde til fremstilling af 13β-alkylgona-4,9,11-triener.
DK132703C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK129345B (da) Analogifremgangsmåde til fremstilling af 22-fluor-3'''-acyldigoxiner.
DK129036B (da) Fremgangsmåde til fremstilling af N-(diethylaminoethyl)-2-methoxy-4-amino-5-chlor-benzamid.
FI52581C (fi) Menetelmä terapeuttisesti käytettävien N-(1,1-ditienyyli-propyyli-(3)) -fenyylietyyliamiinien valmistamiseksi.
DK131189B (da) Analogifremgangsmåde til fremstilling af 16-hydroxylerede 17alfa-ethynyl-17beta-hydroxy-13beta-alkylgona-4,9,11-trien-3-oner.
DK132121C (da) Fremgangsmade til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion
DK139674B (da) Fremgangsmåde til fremstilling af 6-metylen-5-oxytetracyklin-hydroklorid.
DK127110B (da) Fremgangsmåde til fremstilling af pyranosider af 3β-hydroxy-4-chlor-carda-4,20(22)-dienolider.
DK132320B (da) Fremgangsmåde til fremstilling af 1,4-dicyanobutener.
DK132274B (da) Fremgangsmåde til fremstilling af 3,4-epoxy-4-methyl-pentan-2-on.